Report: Europe Leads in Number of Clinical Trials for Cystic Fibrosis, North America for AML

Europe launched the most clinical trials for cystic fibrosis treatments, while North America leads in those for acute myeloid leukemia, according to a pair of new global trial landscape reports announced by contract research organization Novotech. Global venture funding for R&D on treatments for both diseases topped $1 billion each over the past five years.